Treatment with anti-ErbB2 antibodies and anti-hormonal compounds
US7498030B2 · kind B2 · utility
36Cited by
103References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 9, 2005 |
| Grant date | Mar 3, 2009 |
| Priority date | — |
| Expiry date | Jan 15, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/801
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and anti-hormonal compounds, such as anti-estrogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.